Nolato ABFRA:NBF 82 Gross Margin % is 18.33% as of Mar. 2026, which is 15% above its 10-year median of 15.90. GuruFocus rates FRA:NBF with a GF Score™ of 82/100 and a GF Value™ of €4.74 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Nolato AB ranks worse than 90.31% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Nolato AB's Gross Profit for the
three
months ended in Mar. 2026 was €40.1 Mil. Nolato AB's Revenue for the
three
months ended in Mar. 2026 was €218.8 Mil. Therefore, Nolato AB's Gross Margin % for the quarter that ended in Mar. 2026 was 18.33%.
The historical rank and industry rank for Nolato AB's Gross Margin % or its related term are showing as below:
FRA:NBF'
s Gross Margin % Range Over the Past 10 Years
Min: 13.25 Med: 15.9 Max: 18.28
Current: 18.28
During the past 13 years, the highestGross Margin % of Nolato AB was 18.28%. The lowest was 13.25%. And the median was 15.90%.
FRA:NBF's Gross Margin % is ranked worse than 90.31% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 51.94
vs FRA:NBF: 18.28
Nolato AB had a gross margin of 18.33% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Nolato AB was 2.60% per year.
Nolato AB (FRA:NBF) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Nolato AB had a gross margin of 18.33% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Nolato AB Gross Margin % Related Terms
Nolato AB Gross Margin % Historical Data
* Premium members only.
The historical data trend for Nolato AB's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:NBF vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, Nolato AB's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nolato AB Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nolato AB's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Nolato AB's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Nolato AB (FRA:NBF) has a Gross Margin % of 18.33% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Nolato AB and its competitors. This is 15% above median its historical median of 15.90. Over the past decade, Nolato AB's Gross Margin % has ranged from 13.25 to 18.28. According to the industry distribution chart, Nolato AB ranks #727 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 90.3%.
Is Nolato AB's Gross Margin % too high?
Nolato AB's current Gross Margin % of 18.33% is 15% above median its 10-year median of 15.90. Over the past 10 years, this metric has ranged from a low of 13.25 to a high of 18.28. The Medical Devices & Instruments industry median Gross Margin % is 51.94. Nolato AB's value of 18.33% is 64.7% below this industry median. Based on the distribution chart, Nolato AB ranks #727 out of 805 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Nolato AB has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nolato AB's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Nolato AB ranks #727 out of 805 companies for Gross Margin %. This places Nolato AB in the lower half of its industry. The industry median Gross Margin % is 51.94. Nolato AB's value of 18.33% is 64.7% below this benchmark. Historically, Nolato AB's own Gross Margin % has ranged from 13.25 to 18.28 over the past decade. While the company's 10-year median is 15.90 vs. the industry median of 51.94, Nolato AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 51.94, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nolato AB's current Gross Margin % of 18.33% is 64.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Nolato AB and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 51.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nolato AB's current Gross Margin % is 18.33%, which is 15% above median its own 10-year median of 15.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nolato AB stock overvalued right now?
Based on GuruFocus' analysis, Nolato AB (FRA:NBF) is currently considered Modestly Undervalued. The stock's GF Value™ is €4.74, compared to a current price of €4.28 — trading 9.8% below its estimated fair value. The current Gross Margin % is 18.33%, which is 15% above median its 10-year median of 15.90 and 64.7% below the Medical Devices & Instruments industry median of 51.94. Nolato AB's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Nolato AB (FRA:NBF), the current Gross Margin % is 18.33% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nolato AB (FRA:NBF) Overvalued in 2026?
Based on GuruFocus' analysis, Nolato AB stock appears to be undervalued.
The current stock price of €4.28 is trading 9.8% below its estimated GF Value™ of €4.74.
GuruFocus considers Nolato AB to be Modestly Undervalued.
Key valuation signals for FRA:NBF:
Gross Margin %: 18.33% (15% above median its 10-year median of 15.90)
GF Value™: €4.74 vs. price of €4.28 (9.8% below fair value)
Industry Position: 64.7% below the Medical Devices & Instruments median (#727 of 805)
No single metric tells the full story. See the FRA:NBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nolato AB is a Swedish company that develops and manufactures plastic, silicone, and thermoplastic elastomer products. The firm's operations are organized into two segments: Medical Solutions and Engineered Solutions. The company generates the majority of its revenue from the Medical Solutions segment, which is engaged in the development and manufacture of complex product systems and components for medical devices, the pharmaceutical industry, and diagnostics. The Engineered Solutions design, development, industrialization, and manufacture of subsystems and ready-packaged products for a range of industries, including offerings within EMC and thermal solutions. Geographically, the firm generates key revenue from the Rest of Europe and the United States.
82GF Score
Get the complete analysis for FRA:NBF
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:NBF has been successfully added to your 
